In summary, Our study illustrates that miR-29b-3p affects the malignant biological activity of AML cells by targeting its downstream HuR, and involves the participation of NF-κB and JAK/STAT signaling pathways. The gene discussed is NFKB1; the disease is acute myeloid leukemia.